Ultra-Long-Acting Schizophrenia Pill Success; What 'Cured' Seth Rogen's ADHD?

— News and commentary from the psychiatry world

MedpageToday
Illustration of a brain shaped maze.

The investigative, once-weekly oral schizophrenia agent LYN-005 -- an ultra-long-acting, extended release version of the antipsychotic risperidone (Risperdal) -- succeeded in a phase II study, Lyndra Therapeutics announced. (FierceBiotech)

Many mental health professionals are seeing patients come in with "eco anxiety," hallmarked by anxiety over climate change and the future of the world. (The Guardian)

Although children born to mothers who used antidepressants in pregnancy are at a higher risk for affective disorders, this link is likely not a causal one. "While other long-term effects of intrauterine exposure to antidepressants remain to be investigated, our work supports antidepressant continuation for women with severe symptoms or a high risk of relapse because untreated psychiatric illness during pregnancy can have negative consequences on the health and development of the child," said lead author Anna-Sophie Rommel, PhD, of Icahn School of Medicine at Mount Sinai in New York City. (Neuropsychopharmacology)

A retrospective chart review deemed electroconvulsive therapy safe and effective for adolescents ages 15 to 18 with a mood disorder, psychotic disorder, catatonia, or neuroleptic malignant syndrome. (Journal of Clinical Psychiatry)

Actor Seth Rogen's father said in an interview with the New York Times Magazine that marijuana cured his son's ADHD and "mild" Tourette's.

One group of researchers dismissed the notion that people can have a true addiction to social media. (Journal of Behavioral Addictions)

In Ontario, Canada, more than 45% of initial psychiatric-related emergency department visits were first-time visits with no previous outpatient contact. (JAMA Network Open)

A 15-year-old hockey player is filing a lawsuit over her alleged boot from the team after confiding her suicidal thoughts to her coach. (ABC 7 Chicago)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.